Nick Rijke
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 04, 2026
Identifying knowledge gaps in reproductive health management for women with multiple sclerosis and healthcare professionals: a scoping review.
Journal: Frontiers in neurology
Published: December 17, 2025
Recommendations for essential medicines for multiple sclerosis in low-resource settings.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 01, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings.
Journal: Multiple sclerosis and related disorders
Published: February 25, 2025
GRADE notes 5: comparing a new intervention with an established treatment. Practical and methodological issues.
Journal: Journal of clinical epidemiology
Published: January 12, 2025
WHO considers multiple sclerosis treatments essential.
Journal: The Lancet. Neurology
Published: October 06, 2023
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 04, 2022
Ethical use of off-label disease-modifying therapies for multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 26, 2021
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 24, 2021
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic.
Journal: Multiple sclerosis and related disorders
Published: April 14, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Journal: Neurology
Published: February 12, 2021
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: November 11, 2020
Last Updated: 09/26/2026